Mon panier

Mouse Activin RIIA / ACVR2A Protein, His Tag, low endotoxin (SPR & HPLC verified)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
ACA-M52H3-200ug
$300.00
ACA-M52H3-1mg
$1110.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Synonyms

    Activin receptor type IIA, ACTRIIA

  • Source

    Mouse Activin RIIA Protein, His Tag (ACA-M52H3) is expressed from human 293 cells (HEK293). It contains AA Ala 20 - Pro 135 (Accession # P27038-1).

    Predicted N-terminus: Ala 20

    Request for sequence
  • Molecular Characterization

    Activin RIIA Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 15.3 kDa. The protein migrates as 25-35 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-HPLC.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Affichage des données

  • SDS-PAGE

    Activin RIIA SDS-PAGE

    Mouse Activin RIIA Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-HPLC

    Activin RIIA SEC-HPLC

    The purity of Mouse Activin RIIA Protein, His Tag (Cat. No. ACA-M52H3) was greater than 95% as determined by SEC-HPLC.

  • Bioactivity-ELISA

     Activin RIIA ELISA

    Immobilized Mouse Activin RIIA Protein, His Tag (Cat. No. ACA-M52H3) at 1 μg/mL (100 μL/well) can bind Bimagrumab with a linear range of 0.05-1 ng/mL (Routinely tested).

    Protocol
  • Bioactivity-SPR

     Activin RIIA SPR

    Mouse Activin RIIA Protein, His Tag (Cat. No. ACA-M52H3) capture on NTA-Series S sensor chip can bind Human Activin A Protein, Tag Free (Cat. No. ACA-H421b) with an affinity constant of 83.8 pM as determined in a SPR assay (Biacore 8K) (QC tested).

    Protocol

Avis des utilisateurs
Publier un commentaire

Introduction de fond

Activin receptor type-2A (ACVR2A) is also known as activin receptor type IIA, ACTR-IIA, ACTRIIA, and ACVR2, and is a single-pass type I membrane protein. ACVR2A belongs to the protein kinase superfamily, the TKL Ser/Thr protein kinase family, and the TGFB receptor subfamily. Upon ligand binding, ACVR2A forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors, which then phosphorylate and activate SMAD transcriptional regulators. ACVR2A also serves as a receptor for activin A, activin B, and inhibin A (the latter in complex with betaglycan). Two type II activin receptors (ACVR2A and ACVR2B) have been identified, which bind different activins with distinct affinities.

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Activin receptor type-2A

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    4 Détails

  • Étape de développement la plus élevée:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Affichage des données
  • Avis des utilisateurs
  • Contexte